Education
About Us
Working with TipRanks
Follow Us
Carl Zeiss Meditec (DE:AFX)
XETRA:AFX
Total Valuation
Carl Zeiss Meditec has a market cap or net worth of €3.60B. The enterprise value is €0.00.
Market Cap€3.60B
Enterprise Value€0.00
Share Statistics
Carl Zeiss Meditec has 89,440,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding89,440,570
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
Carl Zeiss Meditec’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.08M
Profits Per Employee68.90K
Employee Count2,066
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Carl Zeiss Meditec is 25.0. Carl Zeiss Meditec’s PEG ratio is 0.00.
PE Ratio25.0
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow20.45
PEG Ratio0.00
Income Statement
In the last 12 months, Carl Zeiss Meditec had revenue of 2.23B and earned 141.21M in profits. Earnings per share was 1.61.
Revenue2.23B
Gross Profit1.18B
Operating Income256.80M
Pretax Income193.89M
Net Income141.21M
EBITDA346.89M
Earnings Per Share (EPS)1.61
Cash Flow
In the last 12 months, operating cash flow was 183.56M and capital expenditures -39.39M, giving a free cash flow of 144.16M billion.
Operating Cash Flow183.56M
Free Cash Flow144.16M
Free Cash Flow per Share1.61
Dividends & Yields
Carl Zeiss Meditec pays an annual dividend of €0.6, resulting in a dividend yield of 1.5%
Dividend Per Share€0.6
Dividend Yield1.5%
Payout Ratio32.52%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.38
52-Week Price Change-12.31%
50-Day Moving Average43.42
200-Day Moving Average50.46
Relative Strength Index (RSI)38.76
Average Volume (3m)154.89K
Important Dates
Carl Zeiss Meditec upcoming earnings date is Feb 12, 2026, TBA (Confirmed).
Last Earnings DateDec 11, 2025
Next Earnings DateFeb 12, 2026
Ex-Dividend Date―
Financial Position
Carl Zeiss Meditec as a current ratio of ―, with Debt / Equity ratio of 0.00%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Carl Zeiss Meditec has paid 51.55M in taxes.
Income Tax51.55M
Effective Tax Rate―
Enterprise Valuation
Carl Zeiss Meditec EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Carl Zeiss Meditec has €27.27M in cash and marketable securities with €607.37M in debt, giving a net cash position of -€580.10M billion.
Cash & Marketable Securities€27.27M
Total Debt€607.37M
Net Cash-€580.10M
Net Cash Per Share-€6.49
Tangible Book Value Per Share―
Margins
Gross margin is 52.01%, with operating margin of ―, and net profit margin of ―.
Gross Margin52.01%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Carl Zeiss Meditec is €47.46, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€47.46
Price Target Upside17.77% Upside
Analyst ConsensusHold
Analyst Count9
Revenue Growth Forecast7.82%
EPS Growth Forecast-19.80%